AI Enhances Vaccination Safety and Protects Heart Health
A team led by Ju-Chi Liu, Deputy Superintendent of Shuang-Ho Hospital, has developed an innovative cardiac monitoring system that integrates cloud-based AI computation with wearable devices. This system enables real-time monitoring of physiological data, such as electrocardiograms (ECG) and heart sounds, to provide early warnings for potential cardiac side effects following COVID-19 vaccination. The technology not only reduces vaccination risks but also enhances public confidence in vaccines.
Challenges of Detecting Vaccine Side Effects
While COVID-19 vaccines are highly effective in preventing severe illness, some individuals may experience cardiac-related side effects, such as myocarditis, after vaccination. Traditional ECG testing, limited to short time frames, cannot continuously monitor heart activity, making it difficult to detect latent changes. Additionally, the prolonged latency period of vaccine side effects adds to the diagnostic challenge.
Wearable Technology Ensures Real-Time Cardiac Monitoring
This AI-powered cardiac monitoring system uses wearable devices, including ECG wristbands and pulse oximeters, to provide 24/7 continuous heart health tracking. Leveraging advanced AI algorithms, the system precisely analyzes ECG data to identify abnormalities, such as arrhythmias and myocardial damage, at an early stage. It promptly alerts healthcare professionals and users of potential issues. Beyond heart rate analysis, the system offers in-depth waveform analysis and integrates Taiwan-developed microvascular function measurements for a comprehensive cardiac health assessment.
Study Validates Effectiveness in Detecting Vaccine-Related Cardiac Risks
The research team conducted a long-term study involving over 400 participants vaccinated with different COVID-19 vaccines (including BNT, Moderna, and AstraZeneca). Results showed the system effectively detected post-vaccination ECG changes and accurately predicted cardiovascular risks, achieving an AUC (Area Under Curve) score of over 0.7. When ambiguous data were excluded, the accuracy increased to over 0.9. Notably, the system could identify cardiac abnormalities up to three days in advance, enabling timely interventions that reduced cardiac-related complications by 25%. The research has been patented domestically and internationally and published in international SCI-indexed journals.
Future Developments and Broader Applications
Deputy Superintendent Liu emphasized that this system not only monitors COVID-19 vaccine side effects but also has potential applications in the prevention and treatment of other cardiovascular diseases. Moving forward, the team plans to further optimize the system, expand its applications, and promote its adoption in more medical institutions to benefit a broader population.
Resource: AI監測心臟生理數據 預警新冠疫苗副作用
